ATE537454T1 - Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15 - Google Patents
Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15Info
- Publication number
- ATE537454T1 ATE537454T1 AT07108852T AT07108852T ATE537454T1 AT E537454 T1 ATE537454 T1 AT E537454T1 AT 07108852 T AT07108852 T AT 07108852T AT 07108852 T AT07108852 T AT 07108852T AT E537454 T1 ATE537454 T1 AT E537454T1
- Authority
- AT
- Austria
- Prior art keywords
- gdf
- heart failure
- atrial fibrillation
- patients
- assessing heart
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/495—Transforming growth factor [TGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07108852A EP1995596B1 (de) | 2007-05-24 | 2007-05-24 | Verfahren zum Beurteilen von Herzinsuffizienz bei Patienten mit Vorhofflimmern mittels GDF-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE537454T1 true ATE537454T1 (de) | 2011-12-15 |
Family
ID=38190863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07108852T ATE537454T1 (de) | 2007-05-24 | 2007-05-24 | Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7955854B2 (de) |
| EP (1) | EP1995596B1 (de) |
| JP (1) | JP5015318B2 (de) |
| AT (1) | ATE537454T1 (de) |
| ES (1) | ES2379104T3 (de) |
| WO (1) | WO2008142110A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5198565B2 (ja) * | 2007-08-30 | 2013-05-15 | エフ．ホフマン−ラ ロシュ アーゲー | 心疾患に関連する又は関連しないｇｄｆ−１５の上昇の区別のための手段及び方法 |
| JP2011509403A (ja) * | 2008-01-08 | 2011-03-24 | エフ．ホフマン−ラ ロシュ アーゲー | Ｇｄｆ−１５に基づいて救急室を受診する患者のリスクを評価するための手段及び方法 |
| CN105548563B (zh) | 2009-07-27 | 2017-09-22 | 霍夫曼-拉罗奇有限公司 | mimecan在评价心力衰竭中的用途 |
| WO2011048168A1 (en) * | 2009-10-21 | 2011-04-28 | Pronota N.V. | Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof |
| EP2439535A1 (de) * | 2010-10-07 | 2012-04-11 | F. Hoffmann-La Roche AG | Diagnose von Herzerkrankungen im Zusammenhang mit Diabetes und GDF-15 und Troponin als Prädiktor für die Entwicklung von Diabetes mellitus Typ 2 |
| KR101230088B1 (ko) | 2010-11-24 | 2013-02-05 | 연세대학교 산학협력단 | 심방세동의 예후 예측 방법 |
| RU2016147122A (ru) * | 2014-06-13 | 2018-07-16 | Новартис Аг | Применение серелаксина для снижения gdf-15 |
| EP3425392A4 (de) | 2016-02-29 | 2020-02-05 | Public University Corporation Yokohama City University | Verfahren zum nachweis von kastrationsresistentem prostatakrebs und nachweisreagenz |
| CN109328303B (zh) * | 2016-06-17 | 2022-08-09 | 豪夫迈·罗氏有限公司 | 用于预测心房纤颤的复发的循环血管生成素-2 (Ang-2) |
| WO2018167447A1 (en) | 2017-03-14 | 2018-09-20 | University Of Sheffield | Low dose aspirin (1-50 mg) together with antiplatelets such as ticagrelor of anticoagulants |
| JP7127422B2 (ja) | 2017-08-30 | 2022-08-30 | 東ソー株式会社 | 癌を検出する方法及び検出試薬 |
| CN113167799B (zh) * | 2018-07-31 | 2025-01-10 | 豪夫迈·罗氏有限公司 | 循环DKK3(Dickkopf相关蛋白3)在心房颤动评定中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2567738C (en) * | 2004-06-15 | 2010-12-21 | F. Hoffmann-La Roche Ag | The use of cardiac hormones for diagnosing the risk of suffering from a cardiovascular complication as a consequence of cardiotoxic medication |
| EP1859283A1 (de) * | 2005-02-17 | 2007-11-28 | F. Hoffmann-Roche AG | Verwendung des nt-proanp/nt-probnp-verhältnisses zur diagnose von herzfehlfunktionen |
| EP2047275B1 (de) * | 2006-08-04 | 2011-06-01 | Medizinische Hochschule Hannover | Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis |
| JP5198565B2 (ja) * | 2007-08-30 | 2013-05-15 | エフ．ホフマン−ラ ロシュ アーゲー | 心疾患に関連する又は関連しないｇｄｆ−１５の上昇の区別のための手段及び方法 |
-
2007
- 2007-05-24 EP EP07108852A patent/EP1995596B1/de active Active
- 2007-05-24 AT AT07108852T patent/ATE537454T1/de active
- 2007-05-24 ES ES07108852T patent/ES2379104T3/es active Active
-
2008
- 2008-05-21 JP JP2010508842A patent/JP5015318B2/ja active Active
- 2008-05-21 WO PCT/EP2008/056261 patent/WO2008142110A1/en not_active Ceased
-
2009
- 2009-11-19 US US12/621,560 patent/US7955854B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2379104T3 (es) | 2012-04-20 |
| JP5015318B2 (ja) | 2012-08-29 |
| US7955854B2 (en) | 2011-06-07 |
| WO2008142110A1 (en) | 2008-11-27 |
| JP2010528275A (ja) | 2010-08-19 |
| EP1995596B1 (de) | 2011-12-14 |
| US20100159608A1 (en) | 2010-06-24 |
| EP1995596A1 (de) | 2008-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE537454T1 (de) | Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15 | |
| EP4278366A4 (de) | Gesundheitstest- und diagnoseplattform | |
| Bates et al. | Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines | |
| DE602006014535D1 (de) | Verwendung von nt-proanp und nt-probnp zur diagnose von herzerkrankungen | |
| JP2010517618A5 (de) | ||
| ATE533061T1 (de) | Verfahren zur diagnose bakterieller infektionen | |
| JP2008272477A5 (de) | ||
| JP2012529655A5 (de) | ||
| WO2009092386A3 (en) | A new method to measure and characterize microvesicles in the human body fluids | |
| GB201021399D0 (en) | Oligonucleotide probe set and methods of microbiota profiling | |
| WO2009047283A3 (en) | Means and methods for monitoring myocardial infarction and its treatment | |
| JP2018536170A5 (de) | ||
| BR112015014232A2 (pt) | lesão renal aguda | |
| AR076041A1 (es) | Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral | |
| AR071034A1 (es) | Uso de la catepsina c en el diagnostico de susceptibilidad al dolor y para el tratamiento del dolor | |
| ATE550668T1 (de) | Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis | |
| WO2008101154A3 (en) | Immunotherapy for immune suppressed patients | |
| EA201490576A1 (ru) | Молекулярный маркер для ранней диагностики мезотелиомы плевры у пациентов и способы для анализа его экспрессии | |
| WO2008061978A3 (en) | Means and methods for optimization of diagnostic and therapeutic approaches in chronic artery disease based on the detection of troponin t and nt-probnp | |
| JP5006070B2 (ja) | ストレス強度演算方法、及びストレス強度演算装置 | |
| ATE477329T1 (de) | Verfahren zur detektion der in-vivo-aktivität von neurotrypsin, verwendung des verfahrens und verwendung des c-terminal 22-kda-fragments als biomarker bei der diagnose und überwachung von störungen im zusammenhang mit neurotrypsin | |
| JP2012533066A5 (de) | ||
| WO2008125681A8 (en) | Means and methods for assessing the risk of a cardiac intervention in patients suffering from a stable coronary heart disease based on gdf-15 | |
| RU2008147047A (ru) | Способ диагностики хронического генерализованного пародонтита с агрессивным течением | |
| DE602007013615D1 (de) | Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose-patienten |